Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis

被引:87
|
作者
Boonen, S
Mohan, S
Dequeker, J
Aerssens, J
Vanderschueren, D
Verbeke, G
Broos, P
Bouillon, R
Baylink, DJ
机构
[1] Jerry L Pettis Mem Vet Adm Med Ctr, Res Serv 151, Musculoskeletal Dis Ctr, Loma Linda, CA 92357 USA
[2] Katholieke Univ Leuven, Ctr Metab Bone Dis, Louvain, Belgium
[3] Katholieke Univ Leuven, Arthrit & Metab Bone Dis Res Unit, Louvain, Belgium
[4] Katholieke Univ Leuven, Lab Expt Med & Endocrinol, Louvain, Belgium
[5] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA
[6] Loma Linda Univ, Dept Physiol, Loma Linda, CA 92350 USA
[7] Katholieke Univ Leuven, Dept Epidemiol, Louvain, Belgium
[8] Katholieke Univ Leuven, Dept Traumatol & Emergency Surg, Louvain, Belgium
关键词
D O I
10.1359/jbmr.1999.14.12.2150
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Both a decrease in bone formation and an increase in bone resorption have been implicated in the pathogenesis of age-related (type II) femoral neck osteoporosis. While the increase in the bone resorption rate has been shown to be partially related to secondary hyperparathyroidism, the mechanisms underlying the decline in bone formation have not yet been identified. The aim of the present study was to test the hypothesis that the bone formation deficit associated with type II osteoporosis might be due to secondary hyperparathyroidism and/or to a deficiency of the insulin-like growth factor (IGF) system. Circulating concentrations of IGF-I, IGF-TI, IGF binding protein (IGFBP)-3, IGFBP-4, IGFBP-5, 25-hydroxycholecalciferol (25(OH)D-3), and intact parathyroid hormone (PTH) were measured in 50 elderly women after sustaining a hip fracture and in 50 healthy age-matched controls. In addition, serum levels of osteocalcin (OC), skeletal alkaline phosphatase, and N-terminal procollagen peptide and urinary pyridinium cross-links were determined as markers of bone remodeling, and bone mineral density (BMD) was assessed at the proximal femur. In the patient group, serum was drawn within 18 h of the fracture and prior to surgery. Circulating protein concentrations did not change over this time frame. No difference was found between mean IGFBP-4 serum levels in the two groups studied, while mean levels of IGF-I, IGF-II, IGFBP-3, IGFBP-5, 25(OH)D-3, and markers of bone formation were significantly lower (p < 0.006) in patients as compared with healthy subjects. Serum PTH and urinary pyridinium cross-links, however, were markedly increased (p < 0.001) in the osteoporotic group. In pooled data from the normal and osteoporotic populations, age-adjusted multiple regression models based on IGF-I, IGF-II, IGFBP-3, and IGFBP-5 were found to be highly predictive of serum OC (R-2 = 19%,p < 0.001) and BMD of femoral neck (R-2 = 49%,p < 0.0001), consistent with an effect of the anabolic IGF components on overall bone formation rate. Similar models based on 25(OH)D-3 and PTH, however, were statistically unrelated to OC, To address further the potential impact of trauma on circulating IGF system components, we measured IGF system component levels in 10 male patients within 18 h following tibial fracture and in 10 age-matched normal male subjects. There was no significant difference in serum level of any of the IGF system components between the two groups. Although limited by its cross-sectional design, the present study suggests that, in addition to bone resorption resulting from secondary hyperparathyroidism, impaired bone formation associated with deficiency of the IGF system might predispose elderly women to fragility fracture of the proximal femur.
引用
收藏
页码:2150 / 2158
页数:9
相关论文
共 50 条
  • [1] Associations of blood levels of insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-3 in schizophrenic Arab subjects
    Akanji, Abayomi O.
    Ohaeri, Jude U.
    Al-Shammri, Suhail A.
    Fatania, Hasmukh R.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2007, 45 (09) : 1229 - 1231
  • [2] Influence of Polymorphisms in Genes Encoding for Insulin-Like Growth Factor (IGF)-I, Insulin, and IGF-Binding Protein (IGFBP)-3 on IGF-I, IGF-II, and IGFBP-3 Levels in Umbilical Cord Plasma
    Landmann, Eva
    Kollerits, Barbara
    Kreuder, Joachim Gerhard
    Blum, Werner Friedrich
    Kronenberg, Florian
    Rudloff, Silvia
    HORMONE RESEARCH IN PAEDIATRICS, 2012, 77 (06): : 341 - 350
  • [3] Serum levels of insulin-like growth factors (IGF-I and IGF-II) and their binding protein (IGFBP-3) are not elevated in pancreatic cancer
    James D. Evans
    Margaret C. Eggo
    Ian A. Donovan
    Simon R. Bramhall
    John P. Neoptolemos
    International journal of pancreatology, 1997, 22 (2) : 95 - 100
  • [4] Serum Insulin-Like Growth Factor (IGF)-I, IGF-II and IGF Binding Protein -3 Are Not Correlated With Weight of Fetal Rabbits † 907
    Maya K Hunter
    Sharron E Gargosky
    Katie S Nason
    Jose I Labarta
    Ron G Rosenfeld
    Nancy D Binder
    Pediatric Research, 1997, 41 (Suppl 4) : 154 - 154
  • [5] Insulin-like growth factor binding protein (IGFBP)-3-Bound IGF-I and IGFBP-3-Bound IGF-II in growth hormone deficiency
    Belgorosky, A
    Rivarola, MA
    HORMONE RESEARCH, 1999, 52 (02) : 60 - 65
  • [6] Differential regulation of tissue insulin-like growth factor-binding protein (IGFBP)-3, IGF-I and IGF type 1 receptor mRNA levels, and serum IGF-I and IGFBP concentrations by growth hormone and IGF-I
    Lemmey, AB
    Glassford, J
    FlickSmith, HC
    Holly, JMP
    Pell, JM
    JOURNAL OF ENDOCRINOLOGY, 1997, 154 (02) : 319 - 328
  • [7] CHARACTERIZATION OF THE AFFINITIES OF INSULIN-LIKE GROWTH-FACTOR (IGF)-BINDING PROTEINS 1-4 FOR IGF-I, IGF-II, IGF-I/INSULIN HYBRID, AND IGF-I ANALOGS
    OH, Y
    MULLER, HL
    LEE, DY
    FIELDER, PJ
    ROSENFELD, RG
    ENDOCRINOLOGY, 1993, 132 (03) : 1337 - 1344
  • [8] Insulin-like growth factors (IGF-I, free IGF-I, and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation
    Yu, H
    Mistry, J
    Nicar, MJ
    Khosravi, MJ
    Diamandis, A
    van Doorn, J
    Juul, A
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1999, 13 (04) : 166 - 172
  • [9] Insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein (IGFBP)-3 levels in Arab subjects with coronary heart disease
    Akanji, A. O.
    Suresh, C. G.
    Al-Radwan, R.
    Fatania, H. R.
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2007, 67 (05): : 553 - 559
  • [10] A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk
    N E Allen
    A W Roddam
    D S Allen
    I S Fentiman
    I dos Santos Silva
    J Peto
    J M P Holly
    T J Key
    British Journal of Cancer, 2005, 92 : 1283 - 1287